Artesunate is a widely used drug in clinical treatment
of malaria.
The aim of this study was to investigate the therapeutic mechanism
of artesunate on malaria using an integrated strategy of network pharmacology
and serum metabolomics. The mice models of malaria were established
using 2 × 10
7
red blood cells infected with
Plasmodium berghei
ANKA injection. Giemsa and hematoxylin-eosin
(HE) staining were used to evaluate the efficacy of artesunate on
malaria. Next, network pharmacology analysis was applied to identify
target genes. Then, a metabolomics strategy has been developed to
find the possible significant serum metabolites and metabolic pathways
induced by artesunate. Additionally, two parts of the results were
integrated to confirm each other. Giemsa and HE staining results showed
that artesunate significantly inhibited the proliferation of
Plasmodium
and reduced liver and spleen inflammation.
Based on metabolomics, 18 differential endogenous metabolites were
identified as potential biomarkers related to the artesunate for treating
malaria. These metabolites were mainly involved in the relevant pathways
of biosynthesis of unsaturated fatty acids; aminoacyl-tRNA biosynthesis;
valine, leucine, and isoleucine biosynthesis; and phenylalanine, tyrosine,
and tryptophan biosynthesis. The results of the network pharmacology
analysis showed 125 potential target genes related to the treatment
of malaria with artesunate. The functional enrichment was mainly associated
with lipid and atherosclerosis; pathways of prostate cancer and proteoglycans
in cancer; and PI3K-Akt, apoptosis, NF-κB, Th17 cell, and AGE-RAGE
signaling pathways. These findings were partly consistent with the
findings of the metabolism. Our results further suggested that artesunate
could correct the inflammatory response caused by malaria through
Th17 cell and NF-κB pathways. Meanwhile, our work revealed that
cholesterol needed by
Plasmodium berghei
came directly from serum. Cholesterol and palmitic acid may be essential
in the growth and reproduction of
Plasmodium berghei
. In summary, artesunate may have an effect on anti-malarial properties
through multiple targets.